ALLISON PRYTULA: Open Payments
NPI 1033975404 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,479 in 78 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $622 · 2025 $1,479
Food & beverage: $1,479
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $313 |
| AstraZeneca Pharmaceuticals LP | 9 | $192 |
| ABBVIE INC. | 10 | $174 |
| PFIZER INC. | 9 | $153 |
| GlaxoSmithKline, LLC. | 6 | $126 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $113 |
| Xeris Pharmaceuticals, Inc. | 4 | $64 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
| Alnylam Pharmaceuticals Inc. | 2 | $42 |
Products named: Ozempic, XIFAXAN, Wegovy, NURTEC ODT, Rybelsus, UBRELVY, QULIPTA, TRELEGY ELLIPTA.
Industry payments across TN — which companies pay providers there.
